Sarepta Therapeutics (SRPT) PT Raised to $177 at JPMorgan
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Price: $21.33 --0%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Join SI Premium – FREE
JPMorgan analyst Anupam Rama raised the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $177.00 (from $112.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Sarepta Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
- The Erawan Group (ERW:TB) PT Raised to THB4.20 at CLSA
- MongoDB (MDB) PT Raised to $445 at Rosenblatt
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
